Vergent Bioscience, Inc.
Biotechnology company · Minneapolis, Minnesota, United States
Vergent Bioscience, Inc. is a biotechnology company headquartered in Minneapolis, Minnesota, United States. Its earliest recorded incorporation is in 2013. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $2 million in total, most recently in 2022. It has reported private securities offerings to the US SEC, most recently $19 million sold in a notice filed in 2025.
Vergent Bioscience at a glance
What does Vergent Bioscience do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $2 million in total (2022). NIH funding came from the National Cancer Institute.
Private fundraising reported to the SEC
8 Form D notices; the most recent reported $18.7 million sold (2025).
Frequently asked questions about Vergent Bioscience
Where is Vergent Bioscience headquartered?
Vergent Bioscience, Inc. is headquartered in Minneapolis, Minnesota, United States.
What does Vergent Bioscience do?
Vergent Bioscience, Inc. is a biotechnology company.
When was Vergent Bioscience founded?
The earliest incorporation on record for Vergent Bioscience, Inc. is in 2013, according to public company registers.
Similar companies
- Luminary Therapeutics, Inc.Minneapolis, Minnesota, United States
- Objective Biotechnology, Inc.Minneapolis, Minnesota, United States
- Neurotype Inc.Minneapolis, Minnesota, United States
- OX2 Therapeutics, Inc.Minneapolis, Minnesota, United States
- BIO-TECHNE CorpMinneapolis, Minnesota, United States
- Photonic Pharma LLCMinneapolis, Minnesota, United States
- Metselex, IncorporatedMinneapolis, Minnesota, United States
- National Biomedical LLCMinneapolis, Minnesota, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-24. Data licences